对比增强乳腺X线摄影(CEM)与MRI用于乳腺癌分期的「支持CEM」观点
本文从「支持CEM」的视角综述新诊断乳腺癌术前分期的影像策略。CEM联合超声作为单次就诊成像策略时,肿瘤大小测量与MRI相当,检出乳腺癌敏感度相当,但特异度更有利于CEM,假阳性略低;腋窝超声可与CEM同次完成,表现与MRI评估腋窝相当;无需额外MRI主动检出内乳淋巴结转移。
要点
- CEM联合超声单次就诊可完成乳腺癌术前局部分期,肿瘤大小测量与MRI相当。
- CEM与MRI检出乳腺癌敏感度相当,均可发现同侧或对侧额外病灶。
- CEM特异度优于MRI,术前分期假阳性几率略低。
核心结论
- 当CEM联合超声作为单次就诊成像策略完成乳腺癌术前分期时,乳腺MRI几乎没有额外必要。
研究设计与样本
- 本文为综述,从「支持CEM」视角汇总CEM与MRI用于乳腺癌术前分期比较的文献。
诊断标准与关键数值
- CEM与MRI对乳腺癌检出的敏感度相当,均可检出同侧或对侧额外肿瘤灶。
- CEM特异度优于MRI,术前分期假阳性几率略低。
- CEM与MRI在肿瘤大小测量上表现相当。
- 腋窝超声与标准乳腺MRI评估腋窝的表现和局限性相当。
临床应用与阅片要点
- 新诊断乳腺癌术前局部分期可优先采用CEM联合超声单次就诊策略。
- CEM联合超声方案下,无需常规追加乳腺MRI。
- 腋窝评估可在CEM同次就诊时以超声完成。
- 不推荐仅为检出内乳淋巴结转移而额外行MRI。
局限性
- 本文为支持CEM视角的综述,非原始对照研究,未提供样本量、中心数及效应量等数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
In women with newly diagnosed breast cancer, preoperative staging is required to assess disease extent, enabling us to decide on the most optimal treatment strategy. For locoregional staging, assessment of intramammary tumor extent and presence of axillary and perhaps also internal mammary lymph node metastases is required. Due to the similarity in the underlying principle, contrast-enhanced mammography is increasingly considered instead of breast MRI for this purpose. When considering the combination of CEM and US as a single appointment imaging strategy for preoperative staging of breast cancer, there is only limited room for an additional benefit of breast MRI. For tumor size measurements, equal performance of both CEM and MRI are observed. Sensitivity of both techniques for detecting breast cancer is comparable, meaning that both techniques are capable of detecting additional ipsilateral or contralateral tumor foci. However, specificity is in favor of CEM, meaning that there is a slightly lower chance of having false positive findings in preoperative staging of the breast. Axillary US can be performed during the same appointment as CEM, with equal performance and limitations as evaluation of the axilla on standard breast MRI examinations. Finally, there is no need to actively pursue the detection of IMLN metastases, meaning that additional MRI to do so is not required. This review provides a 'pro-CEM' perceptive on the arguments why breast MRI is hardly necessary when CEM in combination with US has been performed as a single appointment imaging strategy in breast cancer patients.
引用
- Lobbes MBI, Heuts EM, Moossdorff M, et al. Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspective. Eur J Radiol. 2021. PMID: 34358810. doi:10.1016/j.ejrad.2021.109883
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。